Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer; Secondary Analysis of the NeoALTTO Randomized Clinical Trial
Ryan L. Powles, MS; David Redmond, PhD; Christos Sotiriou, MD, PhD; Sherene Loi, MD, PhD; Debora Fumagalli, MD, PhD; Paolo Nuciforo, MD; Nadia Harbeck, MD, PhD; Evandro de Azambuja, MD, PhD; Severine Sarp, MD, PhD, MSc; Serena Di Cosimo, MD; Jens Huober, MD; Jose Baselga, MD, PhD; Martine Piccart-Gebhart, MD, PhD; Olivier Elemento, PhD; Lajos Pusztai, MD, PhD; Christos Hatzis, PhD
Manuscript
JAMA oncology
2018
NeoALTTO
